Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

NIH grant for development of cyanovirin-N to prevent sexual transmission of HIV

Nov. 19, 2002

New multiclade HIV vaccine holds promise for broad efficacy

Nov. 18, 2002

Novel HIV integrase inhibitors in early development at Shionogi

Nov. 13, 2002

Novel HIV RT inhibitors in GSK pipeline

Nov. 7, 2002

Coviracil NDA accepted for filing by FDA

Nov. 6, 2002

Novel HIV reverse transcriptase inhibitors in Medivir pipeline

Nov. 5, 2002

GW-433908 phase III program progresses

Oct. 28, 2002

Rega Institute claims novel antiviral compounds

Oct. 25, 2002

Thai AIDSVAX trial cleared to continue

Oct. 24, 2002

Epicyte receives grant for production of HIV hybrid antibodies

Oct. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...